A patient with acute kidney injury (AKI) presents with hyperkalemia, metabolic acidosis, and signs of fluid overload. Which nursing intervention should be prioritized to address the hyperkalemia and prevent life-threatening complications?

B) Prepare the patient for hemodialysis to rapidly decrease serum potassium levels.

A) Administer intravenous furosemide to manage fluid overload.

B) Prepare the patient for hemodialysis to rapidly decrease serum potassium levels.

C) Administer sodium bicarbonate to correct metabolic acidosis.

D) Initiate a low-potassium diet to reduce potassium intake.

A patient with acute kidney injury (AKI) and heart failure presents with hyperkalemia, metabolic acidosis, and fluid overload. Recent diagnostic results indicate a serum creatinine of 4.7 mg/dL, BUN of 68 mg/dL, potassium of 6.2 mEq/L, and an ejection fraction of 35%. Which of the following interventions should the nurse prioritize to stabilize the patient's condition?

B) Prepare the patient for emergent hemodialysis to correct hyperkalemia and acidosis.

A) Administer intravenous furosemide to manage fluid overload and improve respiratory status.

B) Prepare the patient for emergent hemodialysis to correct hyperkalemia and acidosis.

C) Initiate continuous cardiac monitoring and administer sodium polystyrene sulfonate for hyperkalemia.

D) Administer sodium bicarbonate intravenously to correct metabolic acidosis and protect cardiac function.

A patient with severe hyperkalemia and metabolic acidosis is receiving treatment, but their condition is deteriorating. After initial interventions, the patient exhibits new peaked T-waves, persistent hyperkalemia, and hypotension. Which of the following nursing actions is most critical to address first?

B) Prepare the patient for immediate hemodialysis as recommended by nephrology to rapidly correct electrolyte imbalances.

A) Administer an additional dose of intravenous calcium gluconate to stabilize cardiac membranes.

B) Prepare the patient for immediate hemodialysis as recommended by nephrology to rapidly correct electrolyte imbalances.

C) Initiate a higher dose of insulin and dextrose infusion to enhance intracellular potassium shift.

D) Increase the dose of furosemide to enhance renal excretion of potassium through diuresis.

A patient with severe hyperkalemia and metabolic acidosis is receiving treatment including intravenous calcium gluconate, insulin with dextrose, sodium bicarbonate, and furosemide. The patient develops sudden palpitations, increased respiratory distress, and hypotension with a blood pressure of 88/56 mmHg. Despite these interventions, electrolyte analysis shows persistent hyperkalemia at 5.9 mEq/L. Which of the following should the nurse anticipate in the management of this patient’s condition?

B) Prepare the patient for immediate hemodialysis to rapidly correct electrolyte imbalances.

A) Increase the dose of furosemide to enhance diuresis.

B) Prepare the patient for immediate hemodialysis to rapidly correct electrolyte imbalances.

C) Administer an additional dose of intravenous calcium gluconate to stabilize cardiac membranes.

D) Increase the infusion rate of insulin and dextrose to further promote potassium shift.

A patient with acute kidney injury is experiencing acute respiratory failure due to pulmonary edema and is scheduled for continuous renal replacement therapy (CRRT). Which nursing intervention is most critical to monitor during the first few hours of CRRT initiation to ensure patient stability?

C) Measure the patient's blood pressure every 15 minutes to watch for hemodynamic instability.

A) Monitor the patient's urine output hourly to assess kidney function.

B) Assess the patient's lung sounds frequently to detect changes in respiratory status.

C) Measure the patient's blood pressure every 15 minutes to watch for hemodynamic instability.

D) Check electrolyte levels every 4 hours to prevent imbalances.

A patient with acute kidney injury and acute respiratory failure has been started on continuous renal replacement therapy (CRRT) due to fluid overload and hemodynamic instability. As a nurse managing this patient, which of the following interventions is the most critical to ensure the therapeutic effectiveness of CRRT while minimizing complications?

B) Monitor electrolyte levels frequently and adjust CRRT settings as needed to prevent imbalances.

A) Administer diuretics to increase urine output and enhance fluid removal.

B) Monitor electrolyte levels frequently and adjust CRRT settings as needed to prevent imbalances.

C) Increase the CRRT flow rate to expedite clearance of toxins and improve respiratory status.

D) Regularly assess and document the patient's neurological status to detect early signs of dialysis disequilibrium syndrome.

A patient receiving continuous renal replacement therapy (CRRT) for acute kidney injury demonstrates increasing serum potassium levels and persistent metabolic acidosis. Which of the following nursing interventions is the most appropriate to prioritize at this time?

B) Collaborate with the nephrology team to adjust the CRRT settings to enhance solute clearance.

A) Increase the frequency of monitoring the patient's serum electrolyte levels to every 2 hours.

B) Collaborate with the nephrology team to adjust the CRRT settings to enhance solute clearance.

C) Administer a potassium-binding resin as prescribed to rapidly lower potassium levels.

D) Prepare for the insertion of a central venous catheter for potential urgent hemodialysis.

A patient undergoing continuous renal replacement therapy (CRRT) shows increasing serum potassium levels and persistent metabolic acidosis despite treatment adjustments. The patient also develops oliguria with urine output less than 50 mL in 24 hours. As the nurse, what is the most appropriate action to prioritize the patient's care needs?

C) Prepare to administer calcium gluconate to stabilize cardiac membrane potential due to hyperkalemia.

A) Increase the dose of norepinephrine to improve blood pressure and renal perfusion.

B) Collaborate with the nephrology team to further adjust the CRRT prescription to increase solute clearance.

C) Prepare to administer calcium gluconate to stabilize cardiac membrane potential due to hyperkalemia.

D) Initiate fluid restriction to prevent pulmonary congestion from worsening.

A patient with worsening respiratory and hemodynamic status is suspected to have acute respiratory distress syndrome (ARDS) and reduced cardiac output. Which intervention should the nurse prioritize to stabilize the patient's condition while minimizing further complications?

B) Initiate lung-protective ventilation strategies and adjust fluid management.

A) Increase the FiO2 to 100% to maximize oxygen delivery.

B) Initiate lung-protective ventilation strategies and adjust fluid management.

C) Increase norepinephrine infusion to maintain mean arterial pressure above 65 mmHg.

D) Administer high-dose diuretics to manage potential fluid overload.

A 67-year-old male patient with a history of chronic kidney disease and heart failure is undergoing continuous renal replacement therapy (CRRT) in the ICU. Despite recent adjustments to his CRRT prescription, his condition is worsening, with new complications including suspected acute respiratory distress syndrome (ARDS), unstable hemodynamics, and signs of hepatic dysfunction. Given this scenario, what should be the nurse's priority intervention to address the patient's complex condition?

B) Collaborate with the respiratory therapist to adjust the ventilator settings for lung-protective ventilation.

A) Increase the norepinephrine dose to maintain adequate mean arterial pressure (MAP).

B) Collaborate with the respiratory therapist to adjust the ventilator settings for lung-protective ventilation.

C) Initiate immediate dialysis to address potential fluid overload impacting cardiac and respiratory function.

D) Prepare for potential escalation to extracorporeal membrane oxygenation (ECMO) as conventional supports may become insufficient.

acute kidney injury - Nursing Case Study

Pathophysiology

• Primary mechanism: Acute kidney injury (AKI) often results from ischemic insult due to reduced renal perfusion. This decreased blood flow leads to inadequate oxygen delivery, causing tubular epithelial cell injury and necrosis, primarily affecting the proximal tubules and the thick ascending limb of Henle's loop. The loss of cellular integrity disrupts the glomerular filtration barrier, impairing renal function.

• Secondary mechanism: Nephrotoxic injury from drugs or toxins can directly damage renal tubular cells. The accumulation of toxic substances within the nephrons leads to cellular apoptosis or necrosis, exacerbating renal impairment and contributing to tubular obstruction and back-leak of filtrate.

• Key complication: Sustained injury and inflammatory response can lead to acute tubular necrosis (ATN), characterized by further tubular cell death, inflammation, and interstitial edema. These changes exacerbate renal dysfunction and can progress to chronic kidney disease if unreso

Patient Profile

Demographics:

65-year-old male, retired chemical engineer

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Coronary Artery Disease, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril 20 mg daily, Metformin 1000 mg twice daily, Atorvastatin 40 mg nightly, Furosemide 40 mg daily

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Sudden onset of decreased urine output and confusion

• Key symptoms: Oliguria, generalized edema, shortness of breath, fatigue, nausea

• Vital signs: Blood Pressure 88/50 mmHg, Heart Rate 112 bpm, Respiratory Rate 28 breaths per minute, Temperature 100.4°F, Oxygen Saturation 88% on room air

Section 1

New Diagnostic Results:

Upon further investigation, the patient's laboratory results reveal critical insights into his acute kidney injury. The serum creatinine level has sharply increased to 4.7 mg/dL from a baseline of 1.8 mg/dL, indicating significant renal impairment. Blood urea nitrogen (BUN) is markedly elevated at 68 mg/dL, reflecting a profound reduction in glomerular filtration rate. Electrolyte abnormalities are evident, with hyperkalemia noted at 6.2 mEq/L, posing a risk for cardiac arrhythmias. The serum bicarbonate is low at 16 mEq/L, indicating metabolic acidosis consistent with acute tubular necrosis. Urinalysis shows muddy brown casts and a fractional excretion of sodium (FENa) greater than 2%, supporting the diagnosis of intrinsic renal damage.

A chest X-ray demonstrates bilateral pleural effusions and pulmonary edema, correlating with the patient's respiratory distress and hypoxemia. An echocardiogram reveals a reduced ejection fraction of 35%, suggesting acute decompensated heart failure, possibly worsened by fluid overload and myocardial ischemia. Further complicating the scenario, a CT scan of the abdomen rules out obstructive nephropathy but shows evidence of renal parenchymal swelling.

These diagnostic findings necessitate immediate intervention to address the life-threatening hyperkalemia and metabolic acidosis, alongside management of fluid overload and cardiac dysfunction. The patient's complex presentation of AKI, compounded by heart failure and potential nephrotoxic effects from medications, requires a multidisciplinary approach to stabilize his condition and prevent progression to end-stage renal disease.

Section 2

Response to Interventions:

Following the initial interventions, the medical team prioritized correcting the patient's severe hyperkalemia and metabolic acidosis. The patient received intravenous calcium gluconate to stabilize cardiac membranes, reducing the immediate risk of arrhythmias. Concurrently, insulin and dextrose infusion was administered to promote intracellular shift of potassium, alongside sodium bicarbonate to address acidosis. This was supplemented by the administration of furosemide to promote diuresis and facilitate renal excretion of excess potassium. Continuous telemetry monitoring was initiated to detect any emergent arrhythmias.

Despite these measures, the patient exhibited a distressing change in status within hours. He developed sudden onset of palpitations and increased respiratory distress. A repeat ECG revealed new peaked T-waves, and further electrolyte analysis showed persistent hyperkalemia at 5.9 mEq/L, indicating inadequate response to initial treatments. Additionally, his blood pressure dropped to 88/56 mmHg, raising concerns of worsening cardiac output due to both the underlying heart failure and potential progression of renal dysfunction.

The team promptly escalated care by consulting nephrology for possible initiation of renal replacement therapy, given the patient's refractory hyperkalemia and fluid overload. Hemodialysis was considered to rapidly correct electrolyte imbalances and remove excess fluid, potentially stabilizing the cardiac function. The patient's deteriorating condition underscored the complexity of managing acute kidney injury complicated by cardiac dysfunction, highlighting the need for swift and effective multidisciplinary collaboration to prevent further decline.

Section 3

New Complications:

As the team prepared for the initiation of hemodialysis, the patient developed acute respiratory failure. His respiratory rate increased to 36 breaths per minute, and his oxygen saturation dropped to 84% on high-flow nasal cannula. Auscultation revealed bilateral crackles, indicating worsening pulmonary edema, likely exacerbated by fluid overload and left ventricular dysfunction. The patient's ABG showed a pH of 7.22, PaCO2 of 52 mmHg, and PaO2 of 58 mmHg, confirming respiratory acidosis. This acute decompensation necessitated urgent intubation and mechanical ventilation to stabilize his respiratory status.

New diagnostic imaging, including a chest X-ray, revealed diffuse bilateral infiltrates consistent with acute pulmonary edema and possible acute respiratory distress syndrome (ARDS). This respiratory complication added a layer of complexity to the management of his acute kidney injury, as it limited the use of aggressive fluid removal techniques and increased the risk of hemodynamic instability during dialysis. The patient's urine output remained critically low, and his creatinine level continued to rise, now at 5.0 mg/dL, further supporting the need for urgent renal replacement therapy to manage both electrolyte disturbances and fluid overload.

The evolving clinical picture required the team to reassess their strategy. They engaged in a multidisciplinary discussion involving nephrology, cardiology, and critical care specialists to create a comprehensive plan that considered all aspects of the patient's deteriorating condition. The decision was made to initiate continuous renal replacement therapy (CRRT) rather than traditional hemodialysis, as CRRT would allow for a more controlled and gradual fluid and solute removal, minimizing the risk of hemodynamic instability and further compromise of cardiac function. The team prepared to implement this approach, fully aware of the delicate balance required to navigate the patient's complex and rapidly evolving clinical scenario.

Section 4

Response to Interventions

Following the initiation of continuous renal replacement therapy (CRRT), the patient's condition initially showed signs of stabilization. The gradual removal of fluid and solutes helped to alleviate some of the pulmonary congestion, and his oxygen saturation improved to 92% on mechanical ventilation with an FiO2 of 60%. Furthermore, his blood pressure, which had been labile, began to stabilize with a mean arterial pressure (MAP) maintaining at around 65 mmHg, supported by a low-dose norepinephrine infusion. Despite these early positive signs, the team remained vigilant for potential complications inherent in CRRT and the patient's multifaceted condition.

Over the next 24 hours, laboratory results revealed a subtle yet concerning trend. The patient's serum potassium level, which had initially decreased from 6.2 mmol/L to 4.8 mmol/L, began creeping upward again, now at 5.5 mmol/L. Additionally, his serum bicarbonate, which had improved to 18 mmol/L, showed no further increase, indicating ongoing metabolic acidosis. These findings suggested that despite CRRT, the underlying metabolic disturbances were not fully corrected. The nephrology team adjusted the CRRT prescription, increasing both the dialysate flow rate and bicarbonate concentration to more aggressively address these imbalances.

Concurrently, the intensive care team noted a new challenge: the patient developed oliguria, with urine output dropping to less than 50 mL in 24 hours, raising concerns about worsening renal perfusion or potential acute tubular necrosis. The rise in potassium and persistent acidosis necessitated a reassessment of the patient's fluid status and hemodynamic support. The cardiology team was consulted again to evaluate the potential need for additional cardiac support, such as an inotropic agent, to enhance renal perfusion while balancing the risk of exacerbating cardiac workload. This development required ongoing collaborative decision-making, with a focus on optimizing the patient's cardiac function and renal support while monitoring for any signs of multi-organ failure.

Section 5

New Complications

Despite the adjustments made to the CRRT prescription, the patient's condition began to deteriorate further, revealing new complications that added layers of complexity to his clinical picture. Over the next 12 hours, the patient's oxygen saturation decreased to 88% despite increasing the FiO2 to 70%, and his respiratory rate rose to 30 breaths per minute, suggesting the possible development of acute respiratory distress syndrome (ARDS). A chest X-ray was ordered and revealed diffuse bilateral infiltrates, supporting the suspicion of ARDS and complicating his already fragile respiratory status. This necessitated an urgent adjustment in the ventilator settings, including the initiation of a lung-protective strategy to minimize further lung injury.

Simultaneously, the patient's hemodynamic status became more precarious. His heart rate increased to 115 beats per minute, and blood pressure readings became erratic, with MAP fluctuating between 55 and 60 mmHg, despite the norepinephrine infusion being titrated upwards. A repeat echocardiogram was performed, revealing a reduced ejection fraction of 35%, indicative of worsening cardiac function. This development prompted the cardiology team to start dobutamine to support cardiac output and optimize renal perfusion. However, this intervention presented a new challenge, as the increased inotropic support risked further cardiac strain.

As the healthcare team grappled with these evolving complications, they remained acutely aware of the potential for multi-organ dysfunction. The patient's liver function tests indicated a rising bilirubin level, now at 3.5 mg/dL, and an increase in liver enzymes, suggesting hepatic congestion or ischemia. This multifaceted deterioration necessitated a reassessment of the patient's overall management plan, with a focus on integrated support for cardiac, renal, and respiratory systems, while vigilantly monitoring for signs of progressive multi-organ failure. The team prepared for potential escalation measures, including invasive hemodynamic monitoring or extracorporeal membrane oxygenation (ECMO), if conventional supports proved insufficient.